Business Funding Research Ltd - Limited company accounts 20.1

Business Funding Research Ltd - Limited company accounts 20.1


IRIS Accounts Production v22.1.4.3 07312969 Board of Directors 1.7.21 30.6.22 30.6.22 true true false true true false false false true false 1 1 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure073129692021-06-30073129692022-06-30073129692021-07-012022-06-30073129692020-06-30073129692020-07-012021-06-30073129692021-06-3007312969ns16:EnglandWales2021-07-012022-06-3007312969ns15:PoundSterling2021-07-012022-06-3007312969ns11:Director12021-07-012022-06-3007312969ns11:PrivateLimitedCompanyLtd2021-07-012022-06-3007312969ns11:FRS1022021-07-012022-06-3007312969ns11:Audited2021-07-012022-06-3007312969ns11:LargeMedium-sizedCompaniesRegimeForDirectorsReport2021-07-012022-06-3007312969ns11:LargeMedium-sizedCompaniesRegimeForAccounts2021-07-012022-06-3007312969ns11:FullAccounts2021-07-012022-06-300731296912021-07-012022-06-3007312969ns11:Director22021-07-012022-06-3007312969ns11:Director32021-07-012022-06-3007312969ns11:RegisteredOffice2021-07-012022-06-300731296912021-07-012022-06-300731296912020-07-012021-06-3007312969ns6:CurrentFinancialInstruments2022-06-3007312969ns6:CurrentFinancialInstruments2021-06-3007312969ns6:Non-currentFinancialInstruments2022-06-3007312969ns6:Non-currentFinancialInstruments2021-06-3007312969ns6:ShareCapital2022-06-3007312969ns6:ShareCapital2021-06-3007312969ns6:SharePremium2022-06-3007312969ns6:SharePremium2021-06-3007312969ns6:FurtherSpecificReserve3ComponentTotalEquity2022-06-3007312969ns6:FurtherSpecificReserve3ComponentTotalEquity2021-06-3007312969ns6:RetainedEarningsAccumulatedLosses2022-06-3007312969ns6:RetainedEarningsAccumulatedLosses2021-06-3007312969ns6:ShareCapital2020-06-3007312969ns6:RetainedEarningsAccumulatedLosses2020-06-3007312969ns6:SharePremium2020-06-3007312969ns6:FurtherSpecificReserve3ComponentTotalEquity2020-06-3007312969ns6:ShareCapital2020-07-012021-06-3007312969ns6:SharePremium2020-07-012021-06-3007312969ns6:RetainedEarningsAccumulatedLosses2020-07-012021-06-3007312969ns6:FurtherSpecificReserve3ComponentTotalEquity2020-07-012021-06-3007312969ns6:ShareCapital2021-07-012022-06-3007312969ns6:SharePremium2021-07-012022-06-3007312969ns6:RetainedEarningsAccumulatedLosses2021-07-012022-06-3007312969ns6:FurtherSpecificReserve3ComponentTotalEquity2021-07-012022-06-3007312969ns6:NetGoodwill2021-07-012022-06-3007312969ns6:IntangibleAssetsOtherThanGoodwill2021-07-012022-06-3007312969ns6:LeaseholdImprovements2021-07-012022-06-3007312969ns6:FurnitureFittings2021-07-012022-06-3007312969ns6:ComputerEquipment2021-07-012022-06-3007312969ns11:HighestPaidDirector2021-07-012022-06-3007312969ns11:HighestPaidDirector2020-07-012021-06-3007312969ns6:OwnedAssets2021-07-012022-06-3007312969ns6:OwnedAssets2020-07-012021-06-3007312969ns6:NetGoodwill2020-07-012021-06-3007312969ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-07-012022-06-3007312969ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2020-07-012021-06-3007312969ns6:ComputerSoftware2021-07-012022-06-3007312969ns6:ComputerSoftware2020-07-012021-06-300731296922021-07-012022-06-300731296922020-07-012021-06-300731296952021-07-012022-06-300731296952020-07-012021-06-3007312969ns6:NetGoodwill2021-06-3007312969ns6:PatentsTrademarksLicencesConcessionsSimilar2021-06-3007312969ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-06-3007312969ns6:ComputerSoftware2021-06-3007312969ns6:PatentsTrademarksLicencesConcessionsSimilar2021-07-012022-06-3007312969ns6:NetGoodwill2022-06-3007312969ns6:PatentsTrademarksLicencesConcessionsSimilar2022-06-3007312969ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2022-06-3007312969ns6:ComputerSoftware2022-06-3007312969ns6:NetGoodwill2021-06-3007312969ns6:PatentsTrademarksLicencesConcessionsSimilar2021-06-3007312969ns6:DevelopmentCostsCapitalisedDevelopmentExpenditure2021-06-3007312969ns6:ComputerSoftware2021-06-3007312969ns6:ShortLeaseholdAssetsns6:LandBuildings2021-06-3007312969ns6:LeaseholdImprovements2021-06-3007312969ns6:FurnitureFittings2021-06-3007312969ns6:ComputerEquipment2021-06-3007312969ns6:ShortLeaseholdAssetsns6:LandBuildings2021-07-012022-06-3007312969ns6:ShortLeaseholdAssetsns6:LandBuildings2022-06-3007312969ns6:LeaseholdImprovements2022-06-3007312969ns6:FurnitureFittings2022-06-3007312969ns6:ComputerEquipment2022-06-3007312969ns6:ShortLeaseholdAssetsns6:LandBuildings2021-06-3007312969ns6:LeaseholdImprovements2021-06-3007312969ns6:FurnitureFittings2021-06-3007312969ns6:ComputerEquipment2021-06-3007312969ns6:CostValuation2021-06-3007312969ns6:Subsidiary12021-07-012022-06-30073129691ns6:Subsidiary12021-07-012022-06-3007312969ns6:WithinOneYearns6:CurrentFinancialInstruments2022-06-3007312969ns6:WithinOneYearns6:CurrentFinancialInstruments2021-06-3007312969ns6:CurrentFinancialInstruments2021-07-012022-06-3007312969ns6:Non-currentFinancialInstruments2021-07-012022-06-3007312969ns6:BetweenOneTwoYearsns6:Non-currentFinancialInstruments2022-06-3007312969ns6:BetweenOneTwoYearsns6:Non-currentFinancialInstruments2021-06-3007312969ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2022-06-3007312969ns6:BetweenTwoFiveYearsns6:Non-currentFinancialInstruments2021-06-3007312969ns6:WithinOneYear2022-06-3007312969ns6:WithinOneYear2021-06-3007312969ns6:BetweenOneFiveYears2022-06-3007312969ns6:BetweenOneFiveYears2021-06-3007312969ns6:AllPeriods2022-06-3007312969ns6:AllPeriods2021-06-3007312969ns6:Secured2022-06-3007312969ns6:Secured2021-06-3007312969ns6:RetainedEarningsAccumulatedLosses2021-06-3007312969ns6:SharePremium2021-06-3007312969ns6:FurtherSpecificReserve3ComponentTotalEquity2021-06-30
REGISTERED NUMBER: 07312969 (England and Wales)















STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 JUNE 2022

FOR

BUSINESS FUNDING RESEARCH LTD

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2022




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 9

Other Comprehensive Income 10

Balance Sheet 11

Statement of Changes in Equity 12

Cash Flow Statement 13

Notes to the Cash Flow Statement 14

Notes to the Financial Statements 15


BUSINESS FUNDING RESEARCH LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2022







DIRECTORS: Dr S J Bence
T A S Austin
C Songhurst





REGISTERED OFFICE: Cheribourne House
45a Station Road
Willington
Bedford
Bedfordshire
MK44 3QL





REGISTERED NUMBER: 07312969 (England and Wales)





AUDITORS: Baker Noel Limited
Statutory Auditor
Cheribourne House
45A Station Road
Willington
Bedford
Bedfordshire
MK44 3QL

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

STRATEGIC REPORT
FOR THE YEAR ENDED 30 JUNE 2022

The directors present their strategic report for the year ended 30 June 2022.

REVIEW OF BUSINESS
The company has performed well over the past year, despite ongoing macroeconomic uncertainty caused by COVID and wider political events. Revenue continues to grow, achieving year-on-year growth of 38%. The majority of revenue continues to be generated by the sale of subscriptions to our data platform.

As detailed in previous years, standard accounting practices require subscription revenue to be accounted throughout the licence and so the accounts reflect a significant level of deferred revenue shown as a liability on the balance sheet.

We have seen a return to previous, pre-COVID, ways of working. The move back to face-to-face meetings with clients and prospective clients has been reflected in certain costs such as travel and subsistence. In Q2 2022 the company moved head office to larger premises. This incurred large fit-out capital expenditure and associated moving costs.

All development expenditure has been capitalised to provide a relevant picture of the company's financial position and to reflect the income-generating nature of the intellectual property that has been developed.

PRINCIPAL RISKS AND UNCERTAINTIES
The global macroeconomic situation generates numerous risks and uncertainties for the company. Inflationary pressures put a strain on resources and make long-term planning more uncertain. Hits to business confidence and internal budgetary pressures may also be felt. The directors believe that the company is sufficiently well financed and prepared to weather, and indeed grow, through any such shocks.

The company operates almost entirely in sterling, so exchange rate risks from fluctuations are not prevalent in the business.

As always, competitor risks are present. The market for company data is growing at an impressive rate, such that competitive pressure is to be expected. The directors believe that the company is sufficiently proactive, forward-thinking, and experienced to thrive in such an environment, as has been demonstrated historically.

A technology company will always experience the threat of technological risks, such as hacking. The company regularly invests in solutions to mitigate this risk.

ON BEHALF OF THE BOARD:





T A S Austin - Director


17 October 2022

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 JUNE 2022

The directors present their report with the financial statements of the company for the year ended 30 June 2022.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of the sale of subscriptions to funding software.

DIVIDENDS
No dividends will be distributed for the year ended 30 June 2022.

RESEARCH AND DEVELOPMENT
The company has continued to invest heavily in research and development across all areas of its offering.

There have been continued improvements in the efficiency with which data can be ingested into the Beauhurst platform, from both automated and manual sources.

Investment into machine learning has expanded over this financial year to assist with data generation, processing, and quality control.

The product and feature development teams have expanded and delivered a number of high-value features to our users.

FUTURE DEVELOPMENTS
Over the coming years we expect to continue to grow, improving and developing the services we provide to our customers.
The directors are satisfied that the company is sufficiently well financed to continue operations for the foreseeable future, with various options for funding, including lending facilities or equity investment, should any need arise.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 July 2021 to the date of this report.

Dr S J Bence
T A S Austin
C Songhurst

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

REPORT OF THE DIRECTORS
FOR THE YEAR ENDED 30 JUNE 2022


AUDITORS
The auditors, Baker Noel Limited, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





T A S Austin - Director


17 October 2022

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
BUSINESS FUNDING RESEARCH LTD

Opinion
We have audited the financial statements of Business Funding Research Ltd (the 'company') for the year ended 30 June 2022 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 30 June 2022 and of its loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
BUSINESS FUNDING RESEARCH LTD


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
BUSINESS FUNDING RESEARCH LTD


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also:

- Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the company's internal control.

- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.

- Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the company to cease to continue as a going concern.

- Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation (ie. gives a true and fair view).
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Other Matters
The comparative figures for the year ended 30th June 2021, shown within the financial statements have not been audited.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
BUSINESS FUNDING RESEARCH LTD


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Clive Noel (Senior Statutory Auditor)
for and on behalf of Baker Noel Limited
Statutory Auditor
Cheribourne House
45A Station Road
Willington
Bedford
Bedfordshire
MK44 3QL

17 October 2022

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

INCOME STATEMENT
FOR THE YEAR ENDED 30 JUNE 2022

30.6.22 30.6.21
as restated
Notes £    £   

TURNOVER 6,618,498 4,792,765

Administrative expenses 6,969,104 5,216,747
(350,606 ) (423,982 )

Other operating income 384,756 313,688
OPERATING PROFIT/(LOSS) 4 34,150 (110,294 )


Interest payable and similar expenses 5 42,332 92,411
LOSS BEFORE TAXATION (8,182 ) (202,705 )

Tax on loss 6 - -
LOSS FOR THE FINANCIAL YEAR (8,182 ) (202,705 )

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

OTHER COMPREHENSIVE INCOME
FOR THE YEAR ENDED 30 JUNE 2022

30.6.22 30.6.21
as restated
Notes £    £   

LOSS FOR THE YEAR (8,182 ) (202,705 )


OTHER COMPREHENSIVE INCOME
Fair value share options movement 239,308 410,809
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

239,308

410,809
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

231,126

208,104

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

BALANCE SHEET
30 JUNE 2022

30.6.22 30.6.21
as restated
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 8 4,769,267 3,736,230
Tangible assets 9 736,185 105,627
Investments 10 100 100
5,505,552 3,841,957

CURRENT ASSETS
Debtors 11 1,216,296 1,294,538
Cash at bank 634,766 1,106,992
1,851,062 2,401,530
CREDITORS
Amounts falling due within one year 12 4,922,019 3,853,075
NET CURRENT LIABILITIES (3,070,957 ) (1,451,545 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,434,595

2,390,412

CREDITORS
Amounts falling due after more than one
year

13

(749,000

)

(949,000

)

ACCRUALS AND DEFERRED INCOME 17 (266,065 ) (253,026 )
NET ASSETS 1,419,530 1,188,386

CAPITAL AND RESERVES
Called up share capital 18 364 346
Share premium 19 5,120,616 5,120,616
Fair value reserve 19 1,143,819 904,511
Retained earnings 19 (4,845,269 ) (4,837,087 )
SHAREHOLDERS' FUNDS 1,419,530 1,188,386

The financial statements were approved by the Board of Directors and authorised for issue on 17 October 2022 and were signed on its behalf by:





T A S Austin - Director


BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 30 JUNE 2022

Called up Fair
share Retained Share value Total
capital earnings premium reserve equity
£    £    £    £    £   

Balance at 1 July 2020 344 (4,634,382 ) 5,119,117 493,702 978,781

Changes in equity
Issue of share capital 2 - 1,499 - 1,501
Total comprehensive income - (202,705 ) - 410,809 208,104
Balance at 30 June 2021 346 (4,837,087 ) 5,120,616 904,511 1,188,386

Changes in equity
Issue of share capital 18 - - - 18
Total comprehensive income - (8,182 ) - 239,308 231,126
Balance at 30 June 2022 364 (4,845,269 ) 5,120,616 1,143,819 1,419,530

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 JUNE 2022

30.6.22 30.6.21
as restated
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 2,493,097 1,711,337
Interest paid (4,215 ) (76,169 )
Net cash from operating activities 2,488,882 1,635,168

Cash flows from investing activities
Purchase of intangible fixed assets (2,119,208 ) (1,707,396 )
Purchase of tangible fixed assets (748,918 ) (45,576 )
Sale of tangible fixed assets 7,000 280
Net cash from investing activities (2,861,126 ) (1,752,692 )

Cash flows from financing activities
New loans in year - 1,000,000
Loan repayments in year (100,000 ) (875,000 )
Share issue 18 1,500
Net cash from financing activities (99,982 ) 126,500

(Decrease)/increase in cash and cash equivalents (472,226 ) 8,976
Cash and cash equivalents at beginning of
year

2

1,106,992

1,098,016

Cash and cash equivalents at end of year 2 634,766 1,106,992

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE CASH FLOW STATEMENT
FOR THE YEAR ENDED 30 JUNE 2022

1. RECONCILIATION OF LOSS BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS
30.6.22 30.6.21
as restated
£    £   
Loss before taxation (8,182 ) (202,705 )
Depreciation charges 1,153,451 873,247
Loss/(profit) on disposal of fixed assets 44,080 (280 )
Share based payments 239,308 410,809
Government grants (38,117 ) (16,242 )
Finance costs 42,332 92,411
1,432,872 1,157,240
Decrease/(increase) in trade and other debtors 78,242 (309,191 )
Increase in trade and other creditors 981,983 863,288
Cash generated from operations 2,493,097 1,711,337

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 30 June 2022
30.6.22 1.7.21
£    £   
Cash and cash equivalents 634,766 1,106,992
Year ended 30 June 2021
30.6.21 1.7.20
as restated
£    £   
Cash and cash equivalents 1,106,992 1,098,016


3. ANALYSIS OF CHANGES IN NET FUNDS/(DEBT)

At 1.7.21 Cash flow At 30.6.22
£    £    £   
Net cash
Cash at bank 1,106,992 (472,226 ) 634,766
1,106,992 (472,226 ) 634,766
Debt
Debts falling due within 1 year (100,000 ) (100,000 ) (200,000 )
Debts falling due after 1 year (900,000 ) 200,000 (700,000 )
(1,000,000 ) 100,000 (900,000 )
Total 106,992 (372,226 ) (265,234 )

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2022

1. STATUTORY INFORMATION

Business Funding Research Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention except for certain financial instruments, which are shown at fair value.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover represents

a) The amounts earned on subscriptions to a software service net of VAT. Income is recognised on a straight-line basis over the term of the subscription period. Where sales invoices for subscriptions run beyond the year end that proportion of the income is not recognised in sales but shown in creditors as deferred revenue.

b) The amounts earned on consulting work including reporting, which is recognised when invoiced based on stage of completion.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2016 and another business in 2018, is being amortised evenly over its estimated useful life of five years for each business respectively. Goodwill is reviewed by the directors annually for impairment.

Other intangible assets
Other intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised over estimated useful life of five years.

Development expenditure is amortised over estimated useful life of five years.

Cryptocurrencies are being amortised over estimated useful life of ten years.

Amortisation is included in ‘administrative expenses’ in the profit and loss account.

Costs associated with maintaining computer software are recognised as an expense as incurred. Development costs that are directly attributable to the design and testing of identifiable and unique software products controlled by the company are recognised as intangible assets when the following criteria are met:

• it is technically feasible to complete the software so that it will be available for use;
• management intends to complete the software and use or sell it;
• there is an ability to use or sell the software;
• it can be demonstrated how the software will generate probable future economic benefits;
• adequate technical, financial and other resources to complete the development and to use or sell the software are available; and
• the expenditure attributable to the software during its development can be reliably measured.

Other development expenditures that do not meet these criteria are recognised as an expense as incurred. Development costs previously recognised as an expense are not recognised as an asset in a subsequent period.

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - The period of the lease
Fixtures and fittings - 20% on cost
Computer equipment - 33% on cost

Government grants
Government grants are recognised using the accrual model and classified as either a revenue based grant or a capital based grant. Revenue based grants are recognised on a systematic basis over the period in which the entity recognises the related costs for which the grant is intended to compensate.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Financial instruments
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research is written off against profits in the year in which it is incurred. Development expenditure is capitalised and amortised over its useful life. Development expenditure is capitalised so as to reflect the income-generating data platform that has been developed.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Lease incentives are recognised on a straight-line basis over the period of the lease.

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Employee benefits
When employees have rendered service to the company, short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service.

Contingent assets
Contingent assets are not recognised. Contingent assets are disclosed in the financial statements when an inflow of economic benefits is probable.

Share-based payment transactions
The company operates equity-settled share-based compensation plans. The fair value of the services received in exchange for the grant of options is recognised within personnel expenses, with a corresponding increase in equity, over the period that the employees unconditionally become entitled to the awards. The fair value of the options granted is measured using the Black Scholes model, taking into account the terms and conditions upon which the options were granted. The total amount to be expensed over the vesting period is determined by reference to the fair value of the options granted, excluding the impact of any non-market vesting conditions.

At each reporting date, the entity revises its estimates of the number of options that are expected to become exercisable. It recognises the impact of the revision of original estimates, if any, in the income statement, and a corresponding adjustment to equity.

3. EMPLOYEES AND DIRECTORS
30.6.22 30.6.21
as restated
£    £   
Wages and salaries 3,659,913 2,751,896
Social security costs 400,509 256,872
Other pension costs 97,347 68,657
4,157,769 3,077,425

The average number of employees during the year was as follows:
30.6.22 30.6.21
as restated

Operations & strategy 16 11
Commercial 34 19
Research & development 58 46
- 6
108 82

30.6.22 30.6.21
as restated
£    £   
Directors' remuneration 378,241 430,763
Directors' pension contributions to money purchase schemes 8,242 9,133

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

3. EMPLOYEES AND DIRECTORS - continued

The number of directors to whom retirement benefits were accruing was as follows:

Money purchase schemes 1 1

One director received shares under long term incentive schemes (2021 - one director).

Information regarding the highest paid director is as follows:
30.6.22 30.6.21
as restated
£    £   
Emoluments etc 378,241 430,763
Pension contributions to money purchase schemes 8,242 9,133

Included in the directors emoluments are the fair value of share options vested in the year.

The highest paid director exercised share options for C Incentive and D Incentive shares in the year.

4. OPERATING PROFIT/(LOSS)

The operating profit (2021 - operating loss) is stated after charging/(crediting):

30.6.22 30.6.21
as restated
£    £   
Other operating leases 168,443 144,988
Depreciation - owned assets 67,280 46,757
Loss/(profit) on disposal of fixed assets 44,080 (280 )
Goodwill amortisation 6,000 6,000
Development costs amortisation 1,080,130 820,490
Cryptocurrencies amortisation 41 -
Auditors' remuneration 9,500 -

5. INTEREST PAYABLE AND SIMILAR EXPENSES
30.6.22 30.6.21
as restated
£    £   
Bank loan interest 41,206 16,335
Other loan interest - 76,076
Interest on late paid tax 1,126 -
42,332 92,411

6. TAXATION

Analysis of the tax charge
No liability to UK corporation tax arose for the year ended 30 June 2022 nor for the year ended 30 June 2021.

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

6. TAXATION - continued

Tax effects relating to effects of other comprehensive income

30.6.22
Gross Tax Net
£    £    £   
Fair value share options movement 239,308 - 239,308

30.6.21
Gross Tax Net
£    £    £   
Fair value share options movement 410,809 - 410,809

The company has Research and Development (R&D) expenditure that qualifies under the SME R&D Relief which is expected to give rise to a tax refund. See note 22 for this contingent asset.

7. PRIOR YEAR ADJUSTMENT

The accounts include the following prior year adjustments:

a. Deferred Revenue due in more than one year as disclosed in note 17, the accounts to 30th June 2021 show all Deferred Revenue as due within one year, however £253,026 relate to amounts due in more than one year.

b. Amortisation of development costs in 2021 as disclosed in note 8, were overstated. The net effect of the adjustment reduces the loss in 2021 by £48,503.

8. INTANGIBLE FIXED ASSETS
Patents
and Development
Goodwill licences costs Cryptocurrencies Totals
£    £    £    £    £   
COST
At 1 July 2021 155,000 3,500 6,052,360 - 6,210,860
Additions - - 2,119,062 146 2,119,208
At 30 June 2022 155,000 3,500 8,171,422 146 8,330,068
AMORTISATION
At 1 July 2021 141,500 3,500 2,329,630 - 2,474,630
Amortisation for year 6,000 - 1,080,130 41 1,086,171
At 30 June 2022 147,500 3,500 3,409,760 41 3,560,801
NET BOOK VALUE
At 30 June 2022 7,500 - 4,761,662 105 4,769,267
At 30 June 2021 13,500 - 3,722,730 - 3,736,230

The accounts for the year ending 30th June 2021 showed amortisation of development costs totalling £868,993, however this was not in line with the accounting policy and this has been restated to show amortisation for the year of £820,490. The amortisation at 1st July 2021 is restated to £2,329,630

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

9. TANGIBLE FIXED ASSETS
Improvements Fixtures
Short to and Computer
leasehold property fittings equipment Totals
£    £    £    £    £   
COST
At 1 July 2021 - 99,826 77,620 168,310 345,756
Additions 53,873 402,079 130,324 162,642 748,918
Disposals - (99,826 ) (73,096 ) (79,546 ) (252,468 )
At 30 June 2022 53,873 402,079 134,848 251,406 842,206
DEPRECIATION
At 1 July 2021 - 49,083 67,311 123,735 240,129
Charge for year 1,796 17,562 5,493 42,429 67,280
Eliminated on disposal - (53,242 ) (68,733 ) (79,413 ) (201,388 )
At 30 June 2022 1,796 13,403 4,071 86,751 106,021
NET BOOK VALUE
At 30 June 2022 52,077 388,676 130,777 164,655 736,185
At 30 June 2021 - 50,743 10,309 44,575 105,627

10. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 July 2021
and 30 June 2022 100
NET BOOK VALUE
At 30 June 2022 100
At 30 June 2021 100

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Beauhurst Limited
Registered office: 45a Station Road, Willington, Bedford, Beds, MK44 3QL
Nature of business: Dormant company
%
Class of shares: holding
Ordinary 100.00

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

11. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.22 30.6.21
as restated
£    £   
Trade debtors 1,026,336 1,005,744
Other debtors 99,555 149,715
Prepayments 90,405 139,079
1,216,296 1,294,538

12. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.6.22 30.6.21
as restated
£    £   
Bank loans and overdrafts (see note 14) 200,000 100,000
Trade creditors 104,542 104,385
Social security and other taxes 155,543 98,799
VAT 359,878 375,455
Other creditors 40,112 28,413
Credit card 59,283 -
Accrued expenses 279,590 145,882
Deferred revenue 3,723,071 3,000,141
4,922,019 3,853,075

Deferred Revenue - Invoices raised for the subscription service which run beyond the year end have been treated as deferred revenue. These are apportioned based on the period for which the subscription has been invoiced for.

13. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.6.22 30.6.21
as restated
£    £   
Bank loans (see note 14) 700,000 900,000
Directors' loan accounts 49,000 49,000
749,000 949,000

The loan of £49,000 from one of the directors is held as a long term debt and is unlikely to be repaid in the immediate future.

14. LOANS

An analysis of the maturity of loans is given below:

30.6.22 30.6.21
as restated
£    £   
Amounts falling due within one year or on demand:
Bank loans 200,000 100,000

Amounts falling due between one and two years:
Bank loans - 1-2 years 200,000 200,000

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

14. LOANS - continued
30.6.22 30.6.21
as restated
£    £   
Amounts falling due between two and five years:
Bank loans - 2-5 years 500,000 600,000

Amounts falling due in more than five years:

Repayable by instalments
Bank loans more 5 yr by instal - 100,000

15. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
30.6.22 30.6.21
as restated
£    £   
Within one year 101,738 67,232
Between one and five years 1,012,030 -
1,113,768 67,232

16. SECURED DEBTS

The following secured debts are included within creditors:

30.6.22 30.6.21
as restated
£    £   
Bank loans 900,000 1,000,000

The bank loan outstanding is repayable in installments.
The bank loan is secured by a fixed and floating charge over the company's assets.

17. ACCRUALS AND DEFERRED INCOME
30.6.22 30.6.21
as restated
£    £   
Deferred revenue 266,065 253,026

In accounts to 30th June 2021 all deferred revenue was shown as due within one year. However £253,026 related to amounts due in more than 1 year, the accounts comparative figures have been restated to show this.

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.6.22 30.6.21
Value: £ £
342,631 Ordinary 0.001 343 343
3,261 A Ordinary 0.001 3 3
9,412 C Incentive 0.001 9 -
9,412 D Incentive 0.001 9 -
364 346

On 15th December 2021, 9,412 C Incentive Shares with aggregate nominal value of £9.412, were allotted for cash at par.

On 15th December 2021, 9,412 D Incentive Shares with aggregate nominal value of £9.412, were allotted for cash at par.

There are 5 classes of shares, of which 4 are currently in issue:

Ordinary Shares
Ordinary shares hold one vote per share. No restriction on dividends or the repayment of capital.

A Ordinary Shares
No voting rights. Otherwise these rank pari pasu with Ordinary shares.

B Ordinary Shares
No voting rights. Otherwise these rank pari pasu with Ordinary shares.

C Incentive Shares
No voting rights until trigger event at which point one vote per share.

D Incentive Shares
No voting rights until trigger event at which point one vote per share.

19. RESERVES
Fair
Retained Share value
earnings premium reserve Totals
£    £    £    £   

At 1 July 2021 (4,837,087 ) 5,120,616 904,511 1,188,040
Deficit for the year (8,182 ) (8,182 )
Share options - - 239,308 239,308
At 30 June 2022 (4,845,269 ) 5,120,616 1,143,819 1,419,166

BUSINESS FUNDING RESEARCH LTD (REGISTERED NUMBER: 07312969)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2022

20. SHARE-BASED PAYMENT TRANSACTIONS

In February 2018 an equity-settled share-based payment plan was implemented.

Employees are granted shares options in the company as part of the share scheme based on length of service and discretionary criteria set by management. The options are granted with a fixed exercise price and are exercisable after a vesting period individual to each grant. Vesting conditions are based on continued employment in the company for all grants along with time related conditions varied upon the vesting length. Additional conditions are attached for specific management performance on certain additional performance related grants.

The shares stop vesting if an employee leaves employment, however vested shares are still exercisable by all employees and ex-employees up to the 10 year anniversary of the grant date.
On exercise of the options by the employees, the company issues new shares.

All schemes
A reconciliation of share option movements over the year to 30 June 2022 is shown below:

20222021






No.
Weighted
average
exercise
price



No.
Weighted
average
exercise
price
££
Outstanding at 1 July43,331£10.5222,013£9.56
Granted3,581£11.5021,490£11.50
Forfeited(409)£11.30(172)£11.50
Exercised----
Expired----
Outstanding at 30 June46,503£10.5843,331£10.52
Exercisable at 30 June28,386£10.0022,013£9.56

Throughout year ended 30th June 2022 a total of 3,581 additional share options were issued to staff as part of this scheme.

The first options issued in November 2021 totalled 2,160 and had a strike price of £11.50 per share with the expectation that 2,074 share options will be vested. The fair value, using the Black Scholes model, is £37.28 per share. The exercise date is 31 July 2024.

The second options issued in November 2021 totalled 1,421 and had a strike price of £11.50 per share with the expectation that 1,374 share options will be vested. The fair value, using the Black Scholes model, is £37.24 per share. The exercise date is 31 July 2023.

The accounts reflect the amount of £239,308 (2021: £410,809) applicable to the year as a cost in the profit and loss and which movement is shown in the fair value reserve.

21. GOING CONCERN

The financial statements have been prepared on a going concern basis. The shareholders will continue to support the company for the foreseeable future.

22. CONTINGENT ASSETS

The company will complete a Research and Development tax credit claim for the financial year ending 30th June 2022 after the year end. If the claim is successful then the expected tax credit will be £532,654.